title: Catatonic stupor during the course of Parkinson's disease resolved with electroconvulsive therapy.
authors.forename: Kazumasa
authors.initials: K
authors.lastname: Suzuki
authors.forename: Shuichi
authors.initials: S
authors.lastname: Awata
authors.forename: Kae
authors.initials: K
authors.lastname: Nakagawa
authors.forename: Takehisa
authors.initials: T
authors.lastname: Takano
authors.forename: Hiroo
authors.initials: H
authors.lastname: Matsuoka
mesh_terms: D000978:Antiparkinson Agents / Q000009:adverse effects / Q000627:therapeutic use; D002389:Catatonia / Q000175:diagnosis / Q000628:therapy*; D003128:Coma / Q000175:diagnosis / Q000628:therapy*; D003937:Diagnosis, Differential; D004565:Electroconvulsive Therapy; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009459:Neuroleptic Malignant Syndrome / Q000175:diagnosis / Q000628:therapy; D009460:Neurologic Examination; D010300:Parkinson Disease / Q000175:diagnosis / Q000628:therapy*; D011618:Psychotic Disorders / Q000175:diagnosis / Q000628:therapy*; D012008:Recurrence; D013375:Substance Withdrawal Syndrome / Q000175:diagnosis
chemical_list: D000978:Antiparkinson Agents